ARCHIVES

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 4 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

New Publication Describes End-of-Life Care Projects

August 29, 2003

Upper Endoscopy Most Effective When Performed in 3-Year Intervals

July 27, 2012

Senate Legislation Tackles Drug Shortages, Proposes Faster Approval For “Breakthroughs”

April 27, 2012

NHGRI Director Francis Collins To Step Down.

May 30, 2008

Declining Support Among Oncologists For Euthanasia.

October 13, 2000